LONDON–(BUSINESS WIRE)–According to the latest market research report by Technavio, the global
syphilis testing market is expected to reach USD
1.1 billion by 2019.
In this report, Technavio
covers the present scenario and growth prospects of the global
syphilis testing market for 2015-2019. The market size has been
calculated based on revenues generated from the sales of following
- POC syphilis test
Conventional syphilis test (non-treponemal serology and treponemal
“Many companies are expanding their businesses in emerging countries
like China, Singapore, and Thailand, and countries in Latin America
because these economies exhibit immense growth potential. Implementation
of government initiatives to build healthcare infrastructures, increased
healthcare budgets, and advances in technology largely propel the market
growth in these countries,” said Barath Palada, one of Technavio’s lead
industry analysts for diagnostics
“Changes in lifestyles with a growing gay and bisexual population has
resulted in high prevalence of syphilis over the past decade. Growing
awareness of syphilis-related risks and available diagnostic procedures
and treatment options for the disease presents a tremendous opportunity
for vendors to grow in the global syphilis testing market,” added Barath.
Geographic segmentation of global syphilis testing market
Americas: largest region for the global syphilis testing market
The Americas accounted for close TO 49.3% of the global syphilis testing
market in 2014. The market in Americas is expected to grow slowly
because of growing public awareness, and increase in product launches.
The US is among the major contributors for the Americas market on
account of increase in cases of syphilis in the country.
It is estimated that around 56,471 new cases of syphilis were reported
in the US in 2013. Many new vendors are however likely to venture into
Brazil and other Latin America countries during the course of the
forecast period and intensify the competition.
Between 2012 and 2014, the Brazilian Ministry of Health distributed
3,0303,041 tests to 5,488 municipalities for syphilis testing in primary
health care facilities. Such initiatives by governments and non-profit
institutes for syphilis diagnosis are the key drivers of the syphilis
testing market in Latin America.
EMEA: second largest region for the global syphilis testing market
The prevalence of syphilis is gradually increasing in EMEA and the
region accounted for close to 32.5% of the global syphilis testing
market in 2014. In European countries, the market draws significant
contributions from countries such as Ireland, Denmark, Spain, Czech
Republic, the United Kingdom, and Sweden.
According to Public Health England (PHE) health protection report, it is
estimated that in England alone, in 2014, the number of people diagnosed
with syphilis increased from 3,236 to 4,317, an increase of 33% from the
previous year. With this, the introduction of decentralized testing,
establishment of mounting automation in laboratories, increased use of
POC testing, and preference for early disease diagnosis will further
propel the growth of this market in Europe.
To cater to the growing need for timely testing, several pathological
laboratories have installed fully automated systems for accurate disease
diagnosis and shortened turnaround period. Though the number of
laboratories have been declining over the years in countries in Europe,
the volume of POC tests is increasing. In 2014, out of the total
syphilis infected population in Europe, most patients are in early
latent, secondary, and primary stages. These three phases of infected
cases account for close to 88% of the total syphilis infected population
Syphilis testing market in APAC
The syphilis testing market in APAC was valued at close to USD 168.3
million in 2014. APAC accounted for close to 18.2% of the global
syphilis testing market in 2014. The market in APAC is expected to grow
at a faster rate during the forecast period because of increased
incidences of syphilis in emerging countries like China and India,
especially among the bisexual population and pregnant women.
Growing public awareness and an increase in the number of pathology
laboratories and diagnosis centers also propels its growth. Vendors are
anticipated to employ strategies that increase accessibility of their
products through competitive pricing to generate more sales in APAC over
the next four years.
Browse related reports:
Tumor Testing Market in the US 2016-2020
Tissue Diagnostics Market 2016-2020
Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market 2015-2019
Purchase any three reports for the price of one by becoming a
Technavio subscriber. Subscribing to Technavio’s reports allows you to
download any three reports per month for the price of one. Contact firstname.lastname@example.org
with your requirements and a link to our subscription platform.
is a leading global technology research and advisory company. The
company develops over 2000 pieces of research every year, covering more
than 500 technologies across 80 countries. Technavio has about 300
analysts globally who specialize in customized consulting and business
research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research
techniques to ascertain the size and vendor landscape in a range of
markets. Analysts obtain information using a combination of bottom-up
and top-down approaches, besides using in-house market modeling tools
and proprietary databases. They corroborate this data with the data
obtained from various market participants and stakeholders across the
value chain, including vendors, service providers, distributors,
re-sellers, and end-users.
If you are interested in more information, please contact our media team